MetaCap

Entera Bio Insider Trades

NASDAQ: ENTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.31+0.025 (+0.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
8 · $140.88K
Sales
0 · $0
Shares bought / sold
101.50K / 0
Net activity
Net buying $140,882

Entera Bio insider activity

Over the last 12 months, Entera Bio insiders reported 23 transactions on SEC Form 4: 8 open-market purchases and 0 sales. Insiders bought $140,882 and sold $0 worth of stock, for net insider buying of $140,882. The most recent filing shows Rubin Steven D (Director) reporting a transaction in 19,117 shares on Aug 7, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ENTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ENTX insider transactions

Entera Bio insider transactions
DateInsiderTypeSharesValueFiling
Aug 7, 2026Germano Geno JDirectorAward25,014—Form 4
Aug 7, 2026Ellis SeanDirectorAward20,034—Form 4
Aug 7, 2026Taitel HayaDirectorAward20,790—Form 4
Aug 7, 2026Malca YonatanDirectorAward22,815—Form 4
Aug 7, 2026Rubin Steven DDirectorAward19,117—Form 4
Jul 14, 2026Toledano Miranda JayneChief Executive OfficerAward72,993—Form 4
Jul 14, 2026Toledano Miranda JayneChief Executive OfficerAward347,567—Form 4
May 7, 2026Burshtein GregoryChief of R&DAward87,591—Form 4
May 7, 2026Yaacov-Garbeli DanaChief Financial OfficerAward58,394—Form 4
May 7, 2026Galitzer HillelChief Operating OfficerAward72,993—Form 4
Mar 9, 2026Germano Geno JDirectorBuy20,000$26.00KForm 4
Mar 5, 2026Ellis SeanDirectorBuy10,000$12.30KForm 4
Feb 12, 2026Rubin Steven DDirectorBuy5,000$7.45KForm 4
Feb 10, 2026Germano Geno JDirectorBuy20,000$29.80KForm 4
Feb 10, 2026Taitel HayaDirectorBuy7,500$11.10KForm 4
Feb 9, 2026Rubin Steven DDirectorBuy10,000$12.00KForm 4
Feb 9, 2026Ellis SeanDirectorBuy18,000$22.32KForm 4
Jan 1, 2026Malca YonatanDirectorAward30,157—Form 4
Jan 1, 2026Ellis SeanDirectorAward25,371—Form 4
Jan 1, 2026OSTROV GERALD MDirectorAward28,721—Form 4
Jan 1, 2026Taitel HayaDirectorAward26,329—Form 4
Jan 1, 2026LIEBERMAN GERALD MDirectorAward38,294—Form 4
Dec 29, 2025Toledano Miranda JayneChief Executive OfficerBuy11,000$19.91KForm 4
Jul 16, 2025Burshtein GregoryChief of R&DAward26,316—Form 4
Jul 16, 2025Yaacov-Garbeli DanaChief Financial OfficerAward26,316—Form 4
Jul 16, 2025Toledano Miranda JayneChief Executive OfficerAward43,860—Form 4
Jul 16, 2025Toledano Miranda JayneChief Executive OfficerAward136,842—Form 4
Apr 28, 2025Galitzer HillelChief Operating OfficerAward26,316—Form 4
Apr 1, 2025LIEBERMAN GERALD MDirectorOption exercise23,952$23.95KForm 4
Jan 15, 2025LIEBERMAN GERALD MDirectorAward10,717—Form 4
Jan 15, 2025Taitel HayaDirectorAward6,922—Form 4
Jan 15, 2025Ellis SeanDirectorAward7,100—Form 4
Jan 15, 2025Malca YonatanDirectorAward8,216—Form 4
Jan 15, 2025OSTROV GERALD MDirectorAward8,038—Form 4
Oct 2, 2024Malca YonatanDirectorAward8,639—Form 4
Oct 2, 2024LIEBERMAN GERALD MDirectorAward11,269—Form 4
Oct 2, 2024OSTROV GERALD MDirectorAward8,452—Form 4
Oct 2, 2024Taitel HayaDirectorAward7,278—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related